Physician profile
Ricardo Silva
NPI 1063405009
$7,832.43
in general payments reported to CMS, 2019-2025
17 companies · $571 in 2025
The $571 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,171 · 2020: $891 · 2021: $772 · 2022: $743 · 2023: $2,524 · 2024: $1,160 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,329 · Consulting Fee: $1,250 · Travel and Lodging: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,328.76 |
| Consulting Fee | $1,250.00 |
| Travel and Lodging | $676.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,783.77 | 2019-2025 | Misight Contact Lens, Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $1,322.79 | 2022-2025 | Infuse, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,158.02 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $648.09 | 2019-2025 | Acuvue |
| Oyster Point Pharma, INC. | $391.03 | 2022-2025 | Tyrvaya |
| Alcon Vision LLC | $300.03 | 2020-2025 | Precision7, Precision 1, Dailies Total1 |
| Sun Pharmaceutical Industries INC. | $219.20 | 2020 | |
| Allergan, INC. | $214.21 | 2021-2022 | |
| Abb Con-Cise Optical Group LLC | $151.51 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $139.48 | 2021 | |
| Maculogix, INC. | $114.61 | 2020 | |
| Regeneron Pharmaceuticals, INC. | $111.10 | 2019 | |
| Biotissue Holdings INC. | $106.82 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $64.05 | 2024-2025 | Xdemvy |
| Visioneering Technologies, INC. | $50.52 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Novartis Pharmaceuticals Corporation | $18.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.